These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 10099846

  • 1. The role of the mesangial cell and its matrix in the pathogenesis of diabetic nephropathy.
    McLennan SV, Death AK, Fisher EJ, Williams PF, Yue DK, Turtle JR.
    Cell Mol Biol (Noisy-le-grand); 1999 Feb; 45(1):123-35. PubMed ID: 10099846
    [Abstract] [Full Text] [Related]

  • 2. High glucose reduces generation of plasmin activity by mesangial cells.
    Fisher EJ, McLennan SV, Yue DK, Turtle JR.
    Microvasc Res; 1997 Mar; 53(2):173-8. PubMed ID: 9143550
    [Abstract] [Full Text] [Related]

  • 3. Effects of glucose on matrix metalloproteinase and plasmin activities in mesangial cells: possible role in diabetic nephropathy.
    McLennan SV, Fisher E, Martell SY, Death AK, Williams PF, Lyons JG, Yue DK.
    Kidney Int Suppl; 2000 Sep; 77():S81-7. PubMed ID: 10997695
    [Abstract] [Full Text] [Related]

  • 4. Tranilast prevents the progression of experimental diabetic nephropathy through suppression of enhanced extracellular matrix gene expression.
    Akahori H, Ota T, Torita M, Ando H, Kaneko S, Takamura T.
    J Pharmacol Exp Ther; 2005 Aug; 314(2):514-21. PubMed ID: 15857946
    [Abstract] [Full Text] [Related]

  • 5. Different roles for TGF-beta and VEGF in the pathogenesis of the cardinal features of diabetic nephropathy.
    Ziyadeh FN.
    Diabetes Res Clin Pract; 2008 Nov 13; 82 Suppl 1():S38-41. PubMed ID: 18842317
    [Abstract] [Full Text] [Related]

  • 6. Transcription factor decoy for AP-1 reduces mesangial cell proliferation and extracellular matrix production in vitro and in vivo.
    Ahn JD, Morishita R, Kaneda Y, Kim HJ, Kim YD, Lee HJ, Lee KU, Park JY, Kim YH, Park KK, Chang YC, Yoon KH, Kwon HS, Park KG, Lee IK.
    Gene Ther; 2004 Jun 13; 11(11):916-23. PubMed ID: 14961072
    [Abstract] [Full Text] [Related]

  • 7. Ginkgo biloba extract prevents glucose-induced accumulation of ECM in rat mesangial cells.
    Ji L, Yin XX, Wu ZM, Wang JY, Lu Q, Gao YY.
    Phytother Res; 2009 Apr 13; 23(4):477-85. PubMed ID: 19003945
    [Abstract] [Full Text] [Related]

  • 8. Apoptosis and extracellular matrix-cell interactions in kidney disease.
    Makino H, Sugiyama H, Kashihara N.
    Kidney Int Suppl; 2000 Sep 13; 77():S67-75. PubMed ID: 10997693
    [Abstract] [Full Text] [Related]

  • 9. Combined effects of moderately elevated blood glucose and locally produced TGF-beta1 on glomerular morphology and renal collagen production.
    Krag S, Nyengaard JR, Wogensen L.
    Nephrol Dial Transplant; 2007 Sep 13; 22(9):2485-96. PubMed ID: 17452404
    [Abstract] [Full Text] [Related]

  • 10. Role of TGF-beta in pathogenesis of diabetic nephropathy.
    Pantsulaia T.
    Georgian Med News; 2006 Feb 13; (131):13-8. PubMed ID: 16575121
    [Abstract] [Full Text] [Related]

  • 11. Irradiation of rat mesangial cells alters the expression of gene products associated with the development of renal fibrosis.
    Zhao W, O'Malley Y, Robbins ME.
    Radiat Res; 1999 Aug 13; 152(2):160-9. PubMed ID: 10409325
    [Abstract] [Full Text] [Related]

  • 12. SPARC regulates cell cycle progression in mesangial cells via its inhibition of IGF-dependent signaling.
    Francki A, Motamed K, McClure TD, Kaya M, Murri C, Blake DJ, Carbon JG, Sage EH.
    J Cell Biochem; 2003 Mar 01; 88(4):802-11. PubMed ID: 12577314
    [Abstract] [Full Text] [Related]

  • 13. Ex vivo transfer of the decorin gene into rat glomerulus via a mesangial cell vector suppressed extracellular matrix accumulation in experimental glomerulonephritis.
    Huijun W, Long C, Zhigang Z, Feng J, Muyi G.
    Exp Mol Pathol; 2005 Feb 01; 78(1):17-24. PubMed ID: 15596056
    [Abstract] [Full Text] [Related]

  • 14. Beneficial regulation of matrixmetalloproteinases and their inhibitors, fibrillar collagens and transforming growth factor-beta by Polypodium leucotomos, directly or in dermal fibroblasts, ultraviolet radiated fibroblasts, and melanoma cells.
    Philips N, Conte J, Chen YJ, Natrajan P, Taw M, Keller T, Givant J, Tuason M, Dulaj L, Leonardi D, Gonzalez S.
    Arch Dermatol Res; 2009 Aug 01; 301(7):487-95. PubMed ID: 19373483
    [Abstract] [Full Text] [Related]

  • 15. Transforming growth factor-beta is a potent inhibitor of extracellular matrix degradation by cultured human mesangial cells.
    Baricos WH, Cortez SL, Deboisblanc M, Xin S.
    J Am Soc Nephrol; 1999 Apr 01; 10(4):790-5. PubMed ID: 10203363
    [Abstract] [Full Text] [Related]

  • 16. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
    Guda K, Claffey KP, Dong M, Nambiar PR, Rosenberg DW.
    Mol Carcinog; 2003 May 01; 37(1):51-9. PubMed ID: 12720300
    [Abstract] [Full Text] [Related]

  • 17. Effect of glucose on matrix metalloproteinase activity in mesangial cells.
    McLennan SV, Yue DK, Turtle JR.
    Nephron; 1998 May 01; 79(3):293-8. PubMed ID: 9678429
    [Abstract] [Full Text] [Related]

  • 18. [Glomerular extracellular matrix in glomerulosclerosis by molecular biology].
    Makino H.
    Nihon Rinsho; 1992 Dec 01; 50(12):3038-45. PubMed ID: 1491457
    [Abstract] [Full Text] [Related]

  • 19. Plasminogen activator inhibitor-1 and diabetic nephropathy.
    Lee HB, Ha H.
    Nephrology (Carlton); 2005 Oct 01; 10 Suppl():S11-3. PubMed ID: 16174279
    [Abstract] [Full Text] [Related]

  • 20. Thrombospondin-1 is an endogenous activator of TGF-beta in experimental diabetic nephropathy in vivo.
    Daniel C, Schaub K, Amann K, Lawler J, Hugo C.
    Diabetes; 2007 Dec 01; 56(12):2982-9. PubMed ID: 17878288
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.